Case Report: dynamic monocyte reprogramming during ALSS therapy in type B HBV-ACLF revealed by single-cell transcriptomics - Poll - MDSpire

Case Report: dynamic monocyte reprogramming during ALSS therapy in type B HBV-ACLF revealed by single-cell transcriptomics

  • By

  • Jiale Xie

  • Jiahua Liu

  • Feiyu Wang

  • Dongxuan Zhang

  • Yuyao Tian

  • Júlio Ken Matsubara

  • Jingxiang Zhang

  • Jie Yin

  • Zian Chen

  • Huimin Liu

  • Xiaoshuang Xu

  • Xin Wang

  • Guifen Liu

  • Jianhua Wang

  • Yansheng Jia

  • Lili Chang

  • Yu Guo

  • Wei Qi

  • Yan Wang

  • May 26, 2026

  • 0 min

Share

Original Source(s)

Case Report: dynamic monocyte reprogramming during ALSS therapy in type B HBV-ACLF revealed by single-cell transcriptomics

  • by Jiale Xie, Jiahua Liu, Feiyu Wang, Dongxuan Zhang, Yuyao Tian, Júlio Ken Matsubara, Jingxiang Zhang, Jie Yin, Zian Chen, Huimin Liu, Xiaoshuang Xu, Xin Wang, Guifen Liu, Jianhua Wang, Yansheng Jia, Lili Chang, Yu Guo, Wei Qi, Yan Wang

  • May 26, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Quantifying the metabolic-inflammatory axis: synergistic value of TyG index and FAI in assessing CAD risk among MAFLD patients

Follicular dendritic cell sarcoma associated with IgG4-related disease: a case report and literature review